Stockreport

GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) [Yahoo! Finance]

GRI Bio, Inc.  (GRI) 
PDF GRI-0621 is a small molecule RAR-ß? dual agonist that inhibits the activity of human iNKT cells. According to the article, 'GRI-0621 has been shown to improve fibrosis [Read more]